Samaritan's Collaborating Scientist to Become McGill's New Research Star
30 nov. 2006 10h49 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 30, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Dr. Vassilios Papadopoulos, the lead scientist...
United States Patent Application Published for Samaritan's Novel Alzheimer's Drug SP-04
21 nov. 2006 10h06 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 21, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today they received notice of the publication of its novel Alzheimer's...
Photo Release -- Samaritan Recognized for HIV Innovation
16 nov. 2006 11h01 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 16, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan PharmaPlaz Ireland, Inc. (AMEX:LIV) a developer of innovative drugs, announced today it has been selected by the...
Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline
14 nov. 2006 14h46 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 14, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Samaritan has reached a definitive agreement to...
Samaritan Receives AMEX Compliance Notice Letter
13 nov. 2006 11h04 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 13, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) announced today, that on November 6, 2006, it received a notice from the American Stock Exchange, Inc. ("AMEX")...
Samaritan Submits IND to FDA for Novel Anti-Amyloidal Alzheimer's Drug Candidate Caprospinol
06 nov. 2006 09h12 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan Pharma Ireland, Inc. (AMEX:LIV) developers of innovative drugs, announced today it has submitted an Investigational...
International Patent Application Published for Samaritan's Novel Alzheimer's Drug Caprospinol
03 nov. 2006 10h27 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today we have received notice of the publication of its novel anti-amyloidal...
Photo Release -- Samaritan Completes Patient Enrollment in Proof of Concept PIIb Clinical Trial for HIV Entry Inhibitor Drug SP-01A
01 nov. 2006 03h10 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 1, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has completed patient enrollment of its Phase IIb (Stage 2) 28 day...
Samaritan to Highlight Oral HIV Entry Inhibitor and Novel Alzheimer's Drug At BioPartnering Europe to Seek Partnering Opportunities
03 oct. 2006 09h30 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will highlight the uniqueness and advantages of its oral HIV...
Taglich Brothers Issues Updated Research Report On Samaritan Pharmaceuticals
19 sept. 2006 10h39 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 19, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that Taglich Brothers published an updated Samaritan...